Phenomenex will operate as a standalone operating company
Phenomenex has signed a definitive agreement to be acquired by Danaher Corporation, a Fortune 150 science and technology company. Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand, its personnel and site locations.
Phenomenex is a leading player in proprietary chromatography consumables, serving the liquid and gas chromatography market. Over the past 30 years Phenomenex has grown to become a leader in the market with more than 7,000 products supporting a broad diversity of applications in drug discovery and development, clinical research, forensic toxicology, petrochemical, environmental analysis and food safety. Its more than 700 employees sell and provide support into 92 countries through direct and distributor channels.
The transaction, which is expected to close by late 2016, is subject to customary closing conditions and regulatory approvals.
EP News Bureau
Comments are closed.